Heather J Leach1, Jessica M Danyluk2, Kathryn C Nishimura3, S Nicole Culos-Reed2,4,5. 1. Department of Health and Exercise Science, Colorado State University, 951 Plum Street, Moby Complex B, Office 205D, Ft. Collins, CO, 80523, USA. heather.leach@colostate.edu. 2. Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N-1N4, Canada. 3. Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, 8205 114St 2-50 Corbett Hall, Edmonton, AB, T6G 2G4, Canada. 4. Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada. 5. Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB, Canada.
Abstract
PURPOSE: Community exercise programs can help maintain or improve health in cancer survivors. However, the most effective and feasible duration of a community exercise program for breast cancer survivors who are undergoing treatment is not known. This pre-post-design study evaluated the effects of the "Breast cancer patients Engaging in Activity while Undergoing Treatment" (BEAUTY) program on physical and psychosocial outcomes after 12 and 24 weeks. METHODS: BEAUTY is an ongoing community exercise and wellness program for breast cancer patients who are undergoing, or within 3 months of completing chemotherapy and radiation. Participants completed assessments at baseline, 12 weeks, and 24 weeks to measure body composition, hand-grip dynamometry, aerobic fitness, and flexibility. Self-report questionnaires assessed fatigue (FACIT-fatigue), cognitive function (FACT-cog), quality of life (QOL) (FACT-B), and depressive symptoms (CES-D). Main analyses were repeated measures general linear model for all outcomes. RESULTS: Assessments at all three time points were completed by N = 63 participants. At 24 weeks, waist to hip ratio (p = .019), duration of the submaximal treadmill test (p = .013), and estimated VO2max (p = .018) improved compared to baseline. Fatigue improved at 24 compared to 12 weeks (p = .002). FACT-B scores improved at 24 weeks when compared to both baseline (p = .002) and 12 weeks (p = .001). Depressive symptoms improved compared to baseline (p = .05) and 12 weeks (p = .009). CONCLUSIONS: Additional benefits were seen after 24 versus 12 weeks, suggesting that a longer duration exercise program during, or shortly after completing treatments for breast cancer, may be necessary to see improvements in fitness and psychosocial outcomes. Findings can be applied to community exercise and rehabilitation programs for breast cancer survivors.
PURPOSE: Community exercise programs can help maintain or improve health in cancer survivors. However, the most effective and feasible duration of a community exercise program for breast cancer survivors who are undergoing treatment is not known. This pre-post-design study evaluated the effects of the "Breast cancerpatients Engaging in Activity while Undergoing Treatment" (BEAUTY) program on physical and psychosocial outcomes after 12 and 24 weeks. METHODS: BEAUTY is an ongoing community exercise and wellness program for breast cancerpatients who are undergoing, or within 3 months of completing chemotherapy and radiation. Participants completed assessments at baseline, 12 weeks, and 24 weeks to measure body composition, hand-grip dynamometry, aerobic fitness, and flexibility. Self-report questionnaires assessed fatigue (FACIT-fatigue), cognitive function (FACT-cog), quality of life (QOL) (FACT-B), and depressive symptoms (CES-D). Main analyses were repeated measures general linear model for all outcomes. RESULTS: Assessments at all three time points were completed by N = 63 participants. At 24 weeks, waist to hip ratio (p = .019), duration of the submaximal treadmill test (p = .013), and estimated VO2max (p = .018) improved compared to baseline. Fatigue improved at 24 compared to 12 weeks (p = .002). FACT-B scores improved at 24 weeks when compared to both baseline (p = .002) and 12 weeks (p = .001). Depressive symptoms improved compared to baseline (p = .05) and 12 weeks (p = .009). CONCLUSIONS: Additional benefits were seen after 24 versus 12 weeks, suggesting that a longer duration exercise program during, or shortly after completing treatments for breast cancer, may be necessary to see improvements in fitness and psychosocial outcomes. Findings can be applied to community exercise and rehabilitation programs for breast cancer survivors.
Entities:
Keywords:
Breast; Exercise; Female; Program evaluation
Authors: M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Jonna K van Vulpen; Petra H M Peeters; Miranda J Velthuis; Elsken van der Wall; Anne M May Journal: Maturitas Date: 2015-12-28 Impact factor: 4.342
Authors: Sandra C Hayes; Sheree Rye; Tracey Disipio; Patsy Yates; John Bashford; Chris Pyke; Christobel Saunders; Diana Battistutta; Elizabeth Eakin Journal: Breast Cancer Res Treat Date: 2012-11-09 Impact factor: 4.872
Authors: Daniel Y T Fong; Judy W C Ho; Bryant P H Hui; Antoinette M Lee; Duncan J Macfarlane; Sharron S K Leung; Ester Cerin; Wynnie Y Y Chan; Ivy P F Leung; Sharon H S Lam; Aliki J Taylor; Kar-keung Cheng Journal: BMJ Date: 2012-01-30
Authors: Pedro Lopez; Daniel A Galvão; Dennis R Taaffe; Robert U Newton; Giovani Souza; Gabriel S Trajano; Ronei S Pinto Journal: Breast Cancer Date: 2020-08-19 Impact factor: 4.239
Authors: Margaret L McNeely; Christopher Sellar; Tanya Williamson; Melissa Shea-Budgell; Anil Abraham Joy; Harold Y Lau; Jacob C Easaw; Albert D Murtha; Jeffrey Vallance; Kerry Courneya; John R Mackey; Matthew Parliament; Nicole Culos-Reed Journal: BMJ Open Date: 2019-09-13 Impact factor: 2.692
Authors: Louise Czosnek; Justin Richards; Eva Zopf; Prue Cormie; Simon Rosenbaum; Nicole M Rankin Journal: BMC Cancer Date: 2021-05-30 Impact factor: 4.430
Authors: Jordan T Lee; Chad W Wagoner; Stephanie A Sullivan; Dean J Amatuli; Kirsten A Nyrop; Erik D Hanson; Lee Stoner; Brian C Jensen; Hyman B Muss; Claudio L Battaglini Journal: World J Clin Oncol Date: 2021-06-24